{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:22:15Z","timestamp":1792686135657,"version":"4.5.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2017,12,2]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              The presence of valvular heart disease (\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              ) may affect the risk of stroke and mortality in patients with atrial fibrillation (\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              ). Community\u2010based estimates of prevalence and outcomes of specific forms of\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              in patients with\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              are lacking.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              We examined the prevalence of\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              , anticoagulation use, mortality, stroke\/transient ischemic attack, and bleeding among a community cohort of patients with\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              . Significant\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              was defined as follows: (1) moderate\/severe mitral stenosis or mechanical valve; (2) bioprosthetic valve, surgical repair, or balloon valvuloplasty; and (3) moderate\/severe aortic regurgitation or stenosis, mitral regurgitation, or tricuspid regurgitation. Proportional hazards models were performed to test the association between\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              groups and outcomes. Among 9748 patients with\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              , 2705 (27.7%) had significant\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              . Anticoagulation use was highest among patients with mitral stenosis\/mechanical valve (91.8%). Compared with individuals with no significant\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              , individuals with aortic regurgitation\/aortic stenosis, mitral regurgitation, or tricuspid regurgitation (hazard ratio, 1.23; 95% confidence interval, 1.07\u20131.42) had the highest risk of death. There were no differences in stroke or transient ischemic attack and major bleeding among individuals with and without significant\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              . Patients with\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              and aortic stenosis had the highest risk of death (hazard ratio, 1.32; 95% confidence interval, 1.08\u20131.62).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Significant\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              is common among patients with\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              in community practice. In a community cohort of patients with\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              and\n              <jats:styled-content style=\"fixed-case\">CHA<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              <jats:styled-content style=\"fixed-case\">DS<\/jats:styled-content>\n              <jats:sub>2<\/jats:sub>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">VAS<\/jats:styled-content>\n              c score \u22652, most were anticoagulated. Individuals with\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              and moderate\u2010to\u2010severe biological\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              have more comorbidities and a higher mortality risk; however, stroke and major bleeding are similar among those with and without significant\n              <jats:styled-content style=\"fixed-case\">VHD<\/jats:styled-content>\n              .\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.117.006475","type":"journal-article","created":{"date-parts":[[2017,12,23]],"date-time":"2017-12-23T01:11:19Z","timestamp":1513991479000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":59,"title":["Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT\u2010AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)"],"prefix":"10.1161","volume":"6","author":[{"given":"Kevin L.","family":"Thomas","sequence":"first","affiliation":[{"name":"Duke University Medical Center, Durham, NC"},{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Larry R.","family":"Jackson","sequence":"additional","affiliation":[{"name":"Duke University Medical Center, Durham, NC"},{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Shrader","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Ansell","sequence":"additional","affiliation":[{"name":"New York University School of Medicine Lenox Hill Hospital, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of California Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Gersh","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Kowey","sequence":"additional","affiliation":[{"name":"Lankenau Institute for Medical Research, Wynnewood, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Mahaffey","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine, Palo Alto, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Singer","sequence":"additional","affiliation":[{"name":"Harvard Medical School and Massachusetts General Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laine","family":"Thomas","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Piccini","sequence":"additional","affiliation":[{"name":"Duke University Medical Center, Durham, NC"},{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Peterson","sequence":"additional","affiliation":[{"name":"Duke University Medical Center, Durham, NC"},{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.014807"},{"key":"e_1_3_3_3_2","first-page":"131","article-title":"Thromboembolic complications of rheumatic heart disease","volume":"5","author":"Abernathy WS","year":"1973","unstructured":"Abernathy WS, Willis PW III. Thromboembolic complications of rheumatic heart disease. Cardiovasc Clin. 1973;5:131\u2013175.","journal-title":"Cardiovasc Clin"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.4871.1113"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.4870.1051"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.24.3.349"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905561"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009638"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310907"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.07.001"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.11.025"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007432"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.19.8.937"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu352"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu305"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.031"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.89.2_Supplement.82S"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.038"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063479"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut263"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut373"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.07.013"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300615"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.117.006475","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:40:49Z","timestamp":1715596849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.117.006475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,2]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12,2]]}},"alternative-id":["10.1161\/JAHA.117.006475"],"URL":"https:\/\/doi.org\/10.1161\/jaha.117.006475","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,2]]},"assertion":[{"value":"2017-07-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-10-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-12-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e006475"}}